KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Non-Current Assets (2016 - 2025)

Ionis Pharmaceuticals has reported Non-Current Assets over the past 17 years, most recently at $533.2 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $533.2 million for Q4 2025, up 39.08% from a year ago — trailing twelve months through Dec 2025 was $1.8 billion (up 26.61% YoY), and the annual figure for FY2025 was $533.2 million, up 39.08%.
  • Non-Current Assets for Q4 2025 was $533.2 million at Ionis Pharmaceuticals, up from $514.1 million in the prior quarter.
  • Over the last five years, Non-Current Assets for IONS hit a ceiling of $533.2 million in Q4 2025 and a floor of $258.7 million in Q2 2021.
  • Median Non-Current Assets over the past 5 years was $348.2 million (2023), compared with a mean of $344.0 million.
  • Biggest five-year swings in Non-Current Assets: crashed 53.62% in 2021 and later surged 39.99% in 2025.
  • Ionis Pharmaceuticals' Non-Current Assets stood at $266.6 million in 2021, then rose by 24.21% to $331.2 million in 2022, then rose by 5.14% to $348.2 million in 2023, then rose by 10.1% to $383.4 million in 2024, then soared by 39.08% to $533.2 million in 2025.
  • The last three reported values for Non-Current Assets were $533.2 million (Q4 2025), $514.1 million (Q3 2025), and $408.0 million (Q2 2025) per Business Quant data.